FDA Clears Lupin API Site Of NDMA Risk, Compliance Efforts Ongoing

 
• By Anju Ghangurde
  
Compliance
'SARTANS' MADE AT A LUPIN SITE HAVE BEEN DEEMED SAFE BY THE FDA
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from India

More from Asia